Is TRT Actually Safe? What Two Decades of Evidence Say
Testosterone replacement therapy has moved from the margins of men’s health into the mainstream. What was once discussed quietly at specialist clinics is now a normal topic in gyms and group chats across Indonesia. But the question every man asks before his first injection is the same: is this safe?
The honest answer, backed by the largest trials ever run on testosterone, is: yes, for the right man, at physiologic doses, with proper monitoring. Each part of that sentence matters, and this guide walks through all of them — including the landmark TRAVERSE trial that settled the biggest safety question of all.
The Heart Question: What TRAVERSE Actually Found
For years, the most serious concern about TRT was cardiovascular risk. That concern was put to the definitive test in the TRAVERSE trial, published in the New England Journal of Medicine in 2023 — 5,246 middle-aged and older men with low testosterone and existing cardiovascular disease or high cardiovascular risk, randomized to testosterone gel or placebo and followed for almost three years.
The result: testosterone was non-inferior to placebo for major adverse cardiac events — heart attack, stroke, and cardiovascular death occurred at essentially the same rate in both groups. In the highest-risk population you could reasonably test, restoring testosterone to normal levels did not increase heart attacks or strokes.
TRAVERSE did flag three things worth knowing: slightly higher rates of atrial fibrillation, pulmonary embolism, and acute kidney injury in the testosterone group. These are exactly why TRT belongs under medical supervision rather than sourced from a gym contact — a clinician screens for clotting history and arrhythmia risk before you start, and monitors after.
Heart-related numbers your clinician tracks on TRT
- Hematocrit — testosterone stimulates red blood cell production; above roughly 54% the blood thickens and clot risk rises. This is the most common lab change on TRT and is manageable by dose adjustment. More detail in our guide to TRT and hematocrit.
- Blood pressure — usually stable at physiologic doses, but men with hypertension should read our guide on taking testosterone with high blood pressure.
- Cholesterol — injectable TRT at replacement doses has modest effects on lipids; see TRT and cholesterol.
Smaller injection doses given more frequently keep levels steadier and reduce side effects — covered in once vs twice weekly injections.
The Other Real Risks — and How They’re Managed
Fertility suppression
This is the most under-discussed risk. Exogenous testosterone signals the brain to shut down its own production, which suppresses sperm production — often profoundly. For men who want children, this is managed from day one, typically by adding HCG; read how HCG preserves fertility on TRT or consider a sperm test before starting.
Prostate
Modern evidence, including TRAVERSE, has not shown that restoring testosterone to normal levels causes prostate cancer. PSA is still checked at baseline and monitored, and active prostate cancer remains a contraindication.
Skin and estrogen effects
Some testosterone converts to estrogen. Managed poorly, that can mean acne (why TRT can cause acne) or breast tissue sensitivity (gynecomastia on TRT). Managed well — right dose, right frequency — these are uncommon.
Sleep apnea
TRT can worsen untreated obstructive sleep apnea; severe untreated OSA should be addressed first. See TRT and sleep apnea.
Who Should Not Start TRT
TRT is not appropriate for men with active prostate or breast cancer, a hematocrit already above 54%, a heart attack or stroke within the past six months, severe untreated sleep apnea, or men actively trying to conceive without a fertility-preserving protocol. A responsible clinic screens for every one of these before writing a prescription — that screening is most of what makes TRT safe.
The Indonesia Factor
Safety in Indonesia has an extra dimension: where the testosterone comes from. Underground and gym-sourced products carry unknown dosing, contamination risk, and no monitoring — most TRT horror stories trace back to unsupervised use at supraphysiologic doses. Clinic-based therapy with pharmaceutical product and scheduled blood work is a different intervention entirely. If you are unsure about the legal side, read our guide on whether testosterone is legal in Indonesia.
What Proper Monitoring Looks Like
Evidence-based TRT follows a simple rhythm: comprehensive blood work before starting (total and free testosterone, hematocrit, PSA, lipids, liver and kidney markers), a follow-up panel at 6–12 weeks to confirm dosing, then checks every 6–12 months once stable. Symptoms are tracked alongside labs — the goal is the lowest dose that resolves symptoms, not the highest number on paper. What that journey feels like is mapped in our 12-week TRT timeline.
The Bottom Line
The largest cardiovascular safety trial ever run found no increase in heart attacks or strokes from testosterone therapy. The real risks — raised hematocrit, suppressed fertility, estrogen-related effects — are known, screenable, and manageable with medical supervision. What makes TRT unsafe is doing it without that supervision.
If you suspect low testosterone, the first step is not a prescription — it is a proper diagnosis. Start with the signs of low testosterone, get tested, and talk to a clinician about whether testosterone replacement therapy is right for you.
This article is for information only and is not a substitute for medical advice. Boost Health Clinic physicians assess every patient individually before any treatment.